FDC Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 531599 |
NSE Symbol : FDC |
P/E(TTM) : 28.70 |
ISIN Demat : INE258B01022 |
Div & Yield% : - |
EPS(TTM) : 19.26 |
Book Value(₹) : 128.81 |
Market Cap(₹Cr) : 9,000.96 |
Face Value(₹) : 1.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 624.14 | 454.23 | 452.22 | 479.70 | 530.04 | 431.20 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 624.14 | 454.23 | 452.22 | 479.70 | 530.04 | 431.20 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 28.15 | 20.72 | 25.33 | 27.39 | 29.78 | 10.15 |
Total Income | 652.29 | 474.95 | 477.55 | 507.08 | 559.82 | 441.34 |
Total Expenditure | 482.45 | 396.39 | 370.31 | 400.99 | 410.03 | 377.32 |
PBIDT | 169.85 | 78.56 | 107.23 | 106.10 | 149.79 | 64.03 |
Interest | 1.29 | 0.94 | 0.97 | 1.05 | 1.04 | 1.15 |
PBDT | 168.55 | 77.61 | 106.27 | 105.05 | 148.75 | 62.88 |
Depreciation | 11.00 | 10.39 | 9.93 | 9.81 | 9.59 | 9.69 |
Tax | 36.00 | 13.20 | 20.40 | 21.52 | 30.50 | 14.80 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 6.57 | 5.82 | -2.44 | 1.67 | 0.11 | 1.15 |
Reported Profit After Tax | 114.99 | 48.19 | 78.38 | 72.04 | 108.55 | 37.24 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 114.99 | 48.19 | 78.38 | 72.04 | 108.55 | 37.24 |
EPS (Unit Curr.) | 7.06 | 2.97 | 4.81 | 4.36 | 6.54 | 2.24 |
EPS (Adj) (Unit Curr.) | 7.06 | 2.97 | 4.81 | 4.36 | 6.54 | 2.24 |
Calculated EPS (Unit Curr.) | 7.06 | 2.96 | 4.81 | 4.42 | 6.54 | 2.24 |
Calculated EPS (Adj) (Unit Curr.) | 7.06 | 2.96 | 4.81 | 4.42 | 6.54 | 2.24 |
Calculated EPS (Ann.) (Unit Curr.) | 28.25 | 11.84 | 19.26 | 17.70 | 26.17 | 8.98 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 28.25 | 11.84 | 19.26 | 17.70 | 26.17 | 8.98 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 16.28 | 16.28 | 16.28 | 16.28 | 16.59 | 16.59 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 27.21 | 17.30 | 23.71 | 22.12 | 28.26 | 14.85 |
PBDTM(%) | 27.01 | 17.09 | 23.50 | 21.90 | 28.06 | 14.58 |
PATM(%) | 18.42 | 10.61 | 17.33 | 15.02 | 20.48 | 8.64 |